$ELOX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Eloxx Pharmaceuticals, Inc.. Get notifications about new insider transactions in Eloxx Pharmaceuticals, Inc. for free.

Page: < prev 1 2 3 4 5 6 ... 6 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 19 2018	ELOX	Eloxx Pharmaceutic ...	Noiman Silvia	Chief Executive Off ...	Grant	A	0.00	141,389	0	141,389	0 to 141.4 K
Jun 19 2018	ELOX	Eloxx Pharmaceutic ...	Kleijwegt Martijn	Director	Option Exercise	A	23.27	40,000	930,800	40,000
Jun 19 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Option Exercise	A	23.27	40,000	930,800	40,000
Jun 19 2018	ELOX	Eloxx Pharmaceutic ...	Avnur Zafrira	Director	Option Exercise	A	23.27	40,000	930,800	40,000
Jun 19 2018	ELOX	Eloxx Pharmaceutic ...	Avnur Zafrira	Director	Option Exercise	A	23.27	40,000	930,800	40,000
May 23 2018	ELOX	Eloxx Pharmaceutic ...	Ward Robert	Chief Executive Off ...	Buy	P	14.34	5,000	71,700	15,000	10 K to 15 K (+50.00 %)
May 18 2018	ELOX	Eloxx Pharmaceutic ...	Huertas Pedro	Chief Medical Offic ...	Grant	A	0.00	33,000	0	137,725	104.7 K to 137.7 K (+31.51 %)
May 11 2018	ELOX	Eloxx Pharmaceutic ...	Huertas Pedro	Chief Medical Offic ...	Option Exercise	A	14.88	104,725	1,558,308	104,725
May 11 2018	ELOX	Eloxx Pharmaceutic ...	Huertas Pedro	Chief Medical Offic ...	Grant	A	0.00	104,725	0	104,725	0 to 104.7 K
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Shabtai Gilad	10% Owner	Buy	P	9.75	75,000	731,250	3,351,770	3.3 M to 3.4 M (+2.29 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Pontifax Management 4 G.P. (20 ...	10% Owner	Buy	P	9.75	93,333	909,997	520,396	427.1 K to 520.4 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Pontifax Management 4 G.P. (20 ...	10% Owner	Buy	P	9.75	172,626	1,683,104	962,504	789.9 K to 962.5 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Pontifax Management 4 G.P. (20 ...	10% Owner	Buy	P	9.75	84,041	819,400	468,585	384.5 K to 468.6 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.75	93,333	909,997	520,396	427.1 K to 520.4 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.75	172,626	1,683,104	962,504	789.9 K to 962.5 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.75	84,041	819,400	468,585	384.5 K to 468.6 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Kleijwegt Martijn	Director	Buy	P	9.75	300,000	2,925,000	2,953,673	2.7 M to 3 M (+11.31 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Buy	P	9.75	93,333	909,997	520,396	427.1 K to 520.4 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Buy	P	9.75	172,626	1,683,104	962,504	789.9 K to 962.5 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Buy	P	9.75	84,041	819,400	468,585	384.5 K to 468.6 K (+21.85 %)
Apr 05 2018	ELOX	Eloxx Pharmaceutic ...	Shabtai Gilad	10% Owner	Buy	P	9.58	2,600	24,908	3,276,770	3.3 M to 3.3 M (+0.08 %)
Apr 05 2018	ELOX	Eloxx Pharmaceutic ...	Shabtai Gilad	10% Owner	Buy	P	9.41	5,700	53,637	3,274,170	3.3 M to 3.3 M (+0.17 %)
Apr 02 2018	ELOX	Eloxx Pharmaceutic ...	Shabtai Gilad	10% Owner	Buy	P	9.64	4,500	43,380	3,268,470	3.3 M to 3.3 M (+0.14 %)
Mar 26 2018	ELOX	Eloxx Pharmaceutic ...	Ward Robert	Chief Executive Off ...	Buy	P	8.99	10,000	89,900	10,000	0 to 10 K
Mar 26 2018	ELOX	Eloxx Pharmaceutic ...	WEAVER GREGORY L	Chief Financial Off ...	Buy	P	8.56	4,500	38,520	4,500	0 to 4.5 K
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	8.00	1,600	12,800	427,063	425.5 K to 427.1 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	8.00	2,959	23,672	789,878	786.9 K to 789.9 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	8.00	1,441	11,528	384,544	383.1 K to 384.5 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	7.55	1,760	13,288	425,463	423.7 K to 425.5 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	7.55	3,255	24,575	786,919	783.7 K to 786.9 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	7.55	1,585	11,967	383,103	381.5 K to 383.1 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Buy	P	8.00	1,600	12,800	427,063	425.5 K to 427.1 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Buy	P	8.00	2,959	23,672	789,878	786.9 K to 789.9 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Buy	P	8.00	1,441	11,528	384,544	383.1 K to 384.5 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Buy	P	7.55	1,760	13,288	425,463	423.7 K to 425.5 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Buy	P	7.55	3,255	24,575	786,919	783.7 K to 786.9 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Kariv Tomer	Director	Buy	P	7.55	1,585	11,967	383,103	381.5 K to 383.1 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Pontifax Management 4 G.P. (20 ...	10% Owner	Buy	P	8.00	1,600	12,800	427,063	425.5 K to 427.1 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Pontifax Management 4 G.P. (20 ...	10% Owner	Buy	P	8.00	2,959	23,672	789,878	786.9 K to 789.9 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Pontifax Management 4 G.P. (20 ...	10% Owner	Buy	P	8.00	1,441	11,528	384,544	383.1 K to 384.5 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Pontifax Management 4 G.P. (20 ...	10% Owner	Buy	P	7.55	1,760	13,288	425,463	423.7 K to 425.5 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Pontifax Management 4 G.P. (20 ...	10% Owner	Buy	P	7.55	3,255	24,575	786,919	783.7 K to 786.9 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Pontifax Management 4 G.P. (20 ...	10% Owner	Buy	P	7.55	1,585	11,967	383,103	381.5 K to 383.1 K (+0.42 %)
Mar 22 2018	ELOX	Eloxx Pharmaceutic ...	Avnur Zafrira	Director	Buy	P	7.60	263	1,999	263	0 to 263
Jan 22 2018	SVON	Eloxx Pharmaceutic ...	Huertas Pedro	Chief Medical Offic ...	Option Exercise	A	6.65	50,000	332,500	50,000
Dec 28 2017	SVON	Eloxx Pharmaceutic ...	Ward Robert	Chief Executive Off ...	Option Exercise	A	8.00	640,785	5,126,280	640,785
Dec 28 2017	SVON	Eloxx Pharmaceutic ...	Ward Robert	Chief Executive Off ...	Option Exercise	A	0.00	640,785	0	640,785
Dec 28 2017	SVON	Eloxx Pharmaceutic ...	Ward Robert	Chief Executive Off ...	Option Exercise	A	8.00	22,427	179,416	22,427
Dec 28 2017	SVON	Eloxx Pharmaceutic ...	Ward Robert	Chief Executive Off ...	Option Exercise	A	0.00	22,427	0	22,427
Dec 22 2017	SVON	Eloxx Pharmaceutic ...	WEAVER GREGORY L	Chief Financial Off ...	Option Exercise	A	7.00	399,266	2,794,862	399,266
Dec 21 2017	SVON	Sevion Therapeutic ...	Opko Health, Inc.	10% Owner	Grant	A	0.00	495,126	0	1,289,818	794.7 K to 1.3 M (+62.30 %)
Dec 21 2017	SVON	Sevion Therapeutic ...	RECTOR DAVID		Option Exercise	A	6.00	27,500	165,000	27,500
Dec 21 2017	SVON	Sevion Therapeutic ...	BRACA JOHN N		Option Exercise	A	6.00	18,190	109,140	18,190
Dec 21 2017	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL		Option Exercise	A	6.00	3,621	21,726	3,621
Dec 21 2017	SVON	Sevion Therapeutic ...	Rubin Steven D	Director	Option Exercise	A	6.00	43,189	259,134	43,189
Nov 07 2017	SVON	Sevion Therapeutic ...	Opko Health, Inc.	10% Owner	Option Exercise	C	0.40	66,667	26,667	0
Nov 07 2017	SVON	Sevion Therapeutic ...	Opko Health, Inc.	10% Owner	Buy	C	0.00	1,250,006	0	15,893,844	14.6 M to 15.9 M (+8.54 %)
Aug 14 2017	SVON	Sevion Therapeutic ...	Opko Health, Inc.	10% Owner	Buy	C	0.10	2,563,699	256,370	14,643,838	12.1 M to 14.6 M (+21.22 %)
Aug 14 2017	SVON	Sevion Therapeutic ...	Opko Health, Inc.	10% Owner	Buy	C	0.10	1,563,123	156,312	12,080,139	10.5 M to 12.1 M (+14.86 %)
Feb 16 2017	SVON	Sevion Therapeutic ...	Rubin Steven D	Director	Option Exercise	A	0.22	160,227	35,250	160,227
Feb 16 2017	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	0.22	109,091	24,000	109,091
Feb 16 2017	SVON	Sevion Therapeutic ...	BRACA JOHN N	Director	Option Exercise	A	0.22	167,045	36,750	167,045
Jun 15 2016	SVON	Sevion Therapeutic ...	Rubin Steven D	Director	Option Exercise	A	0.22	89,773	19,750	89,773
Jun 15 2016	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	0.22	78,409	17,250	78,409
Jun 15 2016	SVON	Sevion Therapeutic ...	BRACA JOHN N	Director	Option Exercise	A	0.22	89,773	19,750	89,773
Nov 23 2015	SVON	Sevion Therapeutic ...	Rubin Steven D	Director	Option Exercise	A	0.50	40,000	20,000	40,000
Nov 23 2015	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	0.50	32,500	16,250	32,500
Nov 23 2015	SVON	Sevion Therapeutic ...	Waksal Harlan	Director	Option Exercise	A	0.50	40,000	20,000	40,000
Nov 23 2015	SVON	Sevion Therapeutic ...	BRACA JOHN N	Director	Option Exercise	A	0.50	42,500	21,250	42,500
Oct 01 2015	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Buy	P	0.61	35,000	21,350	1,598,170	1.6 M to 1.6 M (+2.24 %)
May 20 2015	SVON	Sevion Therapeutic ...	Waksal Harlan	Director	Option Exercise	A	0.97	11,340	11,000	147,693
Feb 23 2015	SVON	Sevion Therapeutic ...	Waksal Harlan	Director	Option Exercise	A	0.54	26,552	14,338	136,353
Nov 20 2014	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.83	3,462	2,873	67,569
Nov 20 2014	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.83	27,882	23,142	64,107
Nov 20 2014	SVON	Sevion Therapeutic ...	THOMPSON JOHN PHD	Scientific Founder	Option Exercise	A	0.83	34,020	28,237	53,391
Nov 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	0.83	42,210	35,034	42,210
Nov 20 2014	SVON	Sevion Therapeutic ...	MARTELL RON	Chief Executive Off ...	Option Exercise	A	0.83	56,364	46,782	456,364
Nov 20 2014	SVON	Sevion Therapeutic ...	Waksal Harlan	Director	Option Exercise	A	0.83	17,168	14,249	109,500
Nov 20 2014	SVON	Sevion Therapeutic ...	Waksal Harlan	Director	Option Exercise	A	0.83	38,034	31,568	92,332
Nov 20 2014	SVON	Sevion Therapeutic ...	Browne Leslie J	President	Option Exercise	A	0.83	42,210	35,034	82,065
Nov 20 2014	SVON	Sevion Therapeutic ...	Rubin Steven D	Director	Option Exercise	A	0.83	3,314	2,751	28,658
Nov 20 2014	SVON	Sevion Therapeutic ...	Rubin Steven D	Director	Option Exercise	A	0.83	25,344	21,036	25,344
Nov 20 2014	SVON	Sevion Therapeutic ...	RECTOR DAVID	Director	Option Exercise	A	0.83	5,270	4,374	78,650
Nov 20 2014	SVON	Sevion Therapeutic ...	RECTOR DAVID	Director	Option Exercise	A	0.83	31,698	26,309	73,380
Nov 20 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	0.83	25,344	21,036	25,344
Nov 20 2014	SVON	Sevion Therapeutic ...	Dondero Richard S	VP - Preclinical Re ...	Option Exercise	A	0.83	28,140	23,356	49,476
Nov 20 2014	SVON	Sevion Therapeutic ...	RIOS MIGUEL DE LOS	VP - Research	Option Exercise	A	0.83	34,020	28,237	147,102
Nov 20 2014	SVON	Sevion Therapeutic ...	GRAZIANO JAMES JOSEPH	Chief Technology Of ...	Option Exercise	A	0.83	28,140	23,356	28,140
Nov 20 2014	SVON	Sevion Therapeutic ...	BROOKS JOEL	Chief Financial Off ...	Option Exercise	A	0.83	28,140	23,356	47,300
Nov 20 2014	SVON	Sevion Therapeutic ...	BRACA JOHN N	Director	Option Exercise	A	0.83	5,270	4,374	77,914
Nov 20 2014	SVON	Sevion Therapeutic ...	BRACA JOHN N	Director	Option Exercise	A	0.83	31,698	26,309	72,644
Jun 17 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	3.00	211,626	634,878	211,626
Jun 17 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	3.00	333,333	999,999	333,333
Jun 17 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	D	3.00	211,626	634,878	0
Jun 17 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	D	3.00	333,333	999,999	0
Jun 16 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	See Remarks	Option Exercise	A	3.00	7,411	22,233	249,974
Jun 16 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	See Remarks	Option Exercise	A	3.00	242,563	727,689	242,563
Jun 16 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	See Remarks	Option Exercise	D	3.00	7,411	22,233	0
Jun 16 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	See Remarks	Option Exercise	D	3.00	242,563	727,689	7,411
Jun 16 2014	SVON	Sevion Therapeutic ...	GRAZIANO JAMES JOSEPH	Chief Technology Of ...	Option Exercise	A	3.00	24,641	73,923	24,641
Jun 16 2014	SVON	Sevion Therapeutic ...	GRAZIANO JAMES JOSEPH	Chief Technology Of ...	Option Exercise	D	3.00	24,641	73,923	0
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	2.00	410	820	13,804
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	2.00	23	46	762
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	4.00	8,185	32,740	276,047
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	4.00	244	976	8,180
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	3.00	7,411	22,233	249,974
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	2.00	13,394	26,788	13,394
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	2.00	739	1,478	739
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	4.00	267,862	1,071,448	267,862
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	4.00	7,936	31,744	7,936
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Option Exercise	A	3.00	242,563	727,689	242,563
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Grant	A	0.00	31,396	0	1,058,970	1 M to 1.1 M (+3.06 %)
May 20 2014	SVON	Sevion Therapeutic ...	SMIDER VAUGHN	Chief Scientific Of ...	Grant	A	0.00	1,027,574	0	1,058,970	31.4 K to 1.1 M (+3,272.95 %)
May 20 2014	SVON	Sevion Therapeutic ...	GRAZIANO JAMES JOSEPH	Chief Technology Of ...	Option Exercise	A	2.00	1,361	2,722	1,361
May 20 2014	SVON	Sevion Therapeutic ...	GRAZIANO JAMES JOSEPH	Chief Technology Of ...	Option Exercise	A	2.00	76	152	76
May 20 2014	SVON	Sevion Therapeutic ...	GRAZIANO JAMES JOSEPH	Chief Technology Of ...	Option Exercise	A	4.00	27,211	108,844	27,211
May 20 2014	SVON	Sevion Therapeutic ...	GRAZIANO JAMES JOSEPH	Chief Technology Of ...	Option Exercise	A	4.00	807	3,228	807
May 20 2014	SVON	Sevion Therapeutic ...	GRAZIANO JAMES JOSEPH	Chief Technology Of ...	Option Exercise	A	3.00	24,641	73,923	24,641
May 20 2014	SVON	Sevion Therapeutic ...	GRAZIANO JAMES JOSEPH	Chief Technology Of ...	Grant	A	0.00	104,386	0	104,386	0 to 104.4 K
May 20 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	2.00	11,688	23,376	11,688
May 20 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	2.00	646	1,292	646
May 20 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	4.00	233,696	934,784	567,029
May 20 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	4.00	6,927	27,708	6,927
May 20 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	3.00	211,626	634,878	544,959
May 20 2014	SVON	Sevion Therapeutic ...	FROST PHILLIP MD ET AL	Director	Grant	A	0.00	896,504	0	1,563,170	666.7 K to 1.6 M (+134.48 %)
May 20 2014	SVON	Sevion Therapeutic ...	RIOS MIGUEL DE LOS	VP- Research	Option Exercise	A	2.65	113,082	299,667	113,082
May 20 2014	SVON	Sevion Therapeutic ...	Isabelle Warren John	Director	Grant	A	0.00	5,000	0	6,038	1 K to 6 K (+481.70 %)
May 20 2014	SVON	Sevion Therapeutic ...	QUICK THOMAS C	Director	Grant	A	0.00	5,000	0	13,149	8.1 K to 13.1 K (+61.36 %)
May 20 2014	SVON	Sevion Therapeutic ...	Van Hulst Jack	Director	Option Exercise	A	2.65	7,500	19,875	43,056
May 20 2014	SVON	Sevion Therapeutic ...	STALDER RUEDI	Director	Option Exercise	A	2.65	7,500	19,875	52,405
May 16 2014	SVON	Sevion Therapeutic ...	QUICK THOMAS C	Director	Option Exercise	A	2.77	10,560	29,251	26,738
May 16 2014	SVON	Sevion Therapeutic ...	BRACA JOHN N	Director	Option Exercise	A	2.77	21,074	58,375	40,946
May 16 2014	SVON	Sevion Therapeutic ...	Waksal Harlan	Director	Option Exercise	A	2.77	21,932	60,752	54,298
May 16 2014	SVON	Sevion Therapeutic ...	RECTOR DAVID	Director	Option Exercise	A	2.77	21,074	58,375	41,682
May 16 2014	SVON	Sevion Therapeutic ...	Van Hulst Jack	Director	Option Exercise	A	2.77	16,788	46,503	35,556
May 16 2014	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	2.77	17,464	48,375	36,406
May 16 2014	SVON	Sevion Therapeutic ...	STALDER RUEDI	Director	Option Exercise	A	2.77	20,306	56,248	44,905
Dec 20 2013	SVON	Sevion Therapeutic ...	Browne Leslie J	President and CEO	Buy	P	4.15	800	3,320	1,290	490 to 1.3 K (+163.27 %)
Sep 16 2013	SVON	Sevion Therapeutic ...	Isabelle Warren John	Director	Option Exercise	A	0.05	265,000	14,310	755,000
Sep 16 2013	SVON	Sevion Therapeutic ...	Waksal Harlan	Director	Option Exercise	A	0.05	530,000	28,620	3,236,572
Sep 16 2013	SVON	Sevion Therapeutic ...	BRACA JOHN N	Director	Option Exercise	A	0.05	371,000	20,034	1,992,215
Sep 16 2013	SVON	Sevion Therapeutic ...	STALDER RUEDI	Director	Option Exercise	A	0.05	265,000	14,310	2,479,851
Sep 16 2013	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.05	318,000	17,172	2,002,193
Sep 16 2013	SVON	Sevion Therapeutic ...	RECTOR DAVID	Director	Option Exercise	A	0.05	371,000	20,034	2,080,765
Sep 16 2013	SVON	Sevion Therapeutic ...	QUICK THOMAS C	Director	Option Exercise	A	0.05	265,000	14,310	1,637,763
Sep 16 2013	SVON	Sevion Therapeutic ...	Browne Leslie J	President and CEO	Option Exercise	A	0.05	1,723,000	93,042	4,157,800
Sep 16 2013	SVON	Sevion Therapeutic ...	BROOKS JOEL	CFO, Secretary, Tre ...	Option Exercise	A	0.05	985,000	53,190	2,177,200
Sep 16 2013	SVON	Sevion Therapeutic ...	Van Hulst Jack	Director	Option Exercise	A	0.05	265,000	14,310	1,876,761
Sep 16 2013	SVON	Sevion Therapeutic ...	THOMPSON JOHN PHD	Chief Scientific Of ...	Option Exercise	A	0.05	985,000	53,190	2,203,276
Sep 16 2013	SVON	Sevion Therapeutic ...	Dondero Richard S	VP Research	Option Exercise	A	0.05	985,000	53,190	2,360,124

Page: < prev 1 2 3 4 5 6 ... 6 next >